BUSINESS● LOWAug 13 · Aug 13, 2026, 8:59 PM
ARS Pharmaceuticals drops on abandoning DTC neffy marketing, Q2 EPS miss
Seeking Alpha Tech
ARS Pharmaceuticals saw its stock drop following the abandonment of its DTC marketing for neffy and a miss on its Q2 EPS. This news impacts the company's market performance and strategic direction.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS16m agoN4,000/$ Exchange Rate: NDC asks why refineries are not workingVanguard NigeriaBUSINESS21m agoAt 50: Brand refresh raises questions about heritage, consumer loyaltyVanguard Nigeria